The most measured man on the planet is considering selling his anti-aging supplement company to focus on his new religion: ...

The 16-person, first-in-human study showed promising safety and efficacy data for delivering insulin intranasally in older ...

Elecsys pTau181 is the first In Vitro Diagnostic Regulation (IVDR) certified test to rule out Alzheimer’s associated amyloid ...

A woman and her partner had been trying to conceive for some time. It turned out that a rare allergy may have been hindering ...

A multi-centre, prospective trial involving 787 subjects across Australia, Europe, and the US formed the basis for the CE ...

Bryan Johnson aims to live beyond death. He is creating Bryan AI, a digital version of himself. This AI will learn from his ...

Bryan Johnson considers shutting down or selling Blueprint, his anti-ageing project, to focus on a new movement called ‘Don't ...

Oats are a nutritious addition to a healthy eating pattern. Learn about the best time of day to eat oats for improved ...

The test was developed in collaboration with Eli Lilly and can be used with other clinical information to rule out Alzheimer's disease as the cause of cognitive decline.

Rakovina Therapeutics Inc., a biopharmaceutical company advancing next-generation cancer therapies through artificial intelligence (AI)-powered drug discovery, has shared a summary of its H1 2025 ...

Platelet-rich plasma (PRP) is a fraction of blood plasma; its concentration of platelets is of great value in regenerative ...

Catching blood cancer early is key — rapid breath analysis could soon replace slower, more expensive diagnostic tools.